Alnylam Pharmaceuticals (ALNY)

$126.47 5.14 (4.24%)
16:00 EDT ALNY Stock Quote Delayed 30 Minutes

7 Potential Biotech Stocks Buyout Targets in 2022

Big biopharma companies usually rely on M&A to get immediate access to a new class of drug or technology, fill in the gap in their pipeline and compensate for revenue loss from patent expiration of blockbuster products.

Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock

7 Lucrative Biotech Stocks With Up to 300% Upside

8 Undervalued Biotech Stocks to Watch

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 15.03B
PE Ratio -16.89
EPS -7.49
Volume (Avg. Vol.) 740,287
Day's Range $124.00 - $128.77
52-Week Range $117.58 - $212.00
Dividend & Yield N/A (N/A)